Aurora Cannabis ACB shares are trading higher on Tuesday in anticipation of the company's fourth-quarter earnings results, which are scheduled after the close today.
On Monday, Jefferies upgraded Aurora from Underperform to Hold and cut his price target from $10.51 to $6.53.
See Also: Jefferies Upgrades Aurora And Tilray, Says Valuations, Estimates 'Now More Realistic'
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, Aurora has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 25 countries.
Aurora Cannabis shares were trading up 17% at $7.40 on Tuesday at the time of publication. The stock has a 52-week high of $62.88 and a 52-week low of $5.30.
Update: Aurora Cannabis Stock Plunges 18% After Q4 Earnings Call
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Top Cannabis Event In New Jersey
Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!